Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies

J Peripher Nerv Syst. 2012 Dec;17(4):426-8. doi: 10.1111/j.1529-8027.2012.00444.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases / economics*
  • Autoimmune Diseases / psychology
  • Autoimmune Diseases / therapy*
  • Chronic Disease
  • Cost Control
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Home Care Services / economics
  • Humans
  • Immunization, Passive / economics*
  • Immunization, Passive / instrumentation
  • Immunoglobulins, Intravenous / therapeutic use
  • Injections, Subcutaneous
  • Peripheral Nervous System Diseases / economics*
  • Peripheral Nervous System Diseases / psychology
  • Peripheral Nervous System Diseases / therapy*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / economics
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / therapy
  • Quality of Life / psychology*
  • Surveys and Questionnaires

Substances

  • Immunoglobulins, Intravenous